Search results for "Heart failure"
Sacubitril-valsartan appears cost-effective in certain heart failure patients
Treatment value was highest in patients with class II heart failure, who also benefited most from treatment in the PARADIGM-HF trial, and improved outcomes with the drug would need to be sustained for at least 36 months to keep the cost per quality-adjusted life-year below a $100,000 threshold.
https://immattersacp.org/weekly/archives/2016/08/30/2.htm
30 Aug 2016
ACP releases joint statement with ACC and AHA on heart failure
ACP, along with the American College of Cardiology Foundation (ACCF) and the American Heart Association (AHA), has released a clinical statement on heart failure.
https://immattersacp.org/weekly/archives/2010/07/27/8.htm
27 Jul 2010
Detecting eating disorders in midlife
Internists are well positioned to spot eating disorder symptoms in older adults, who can suffer more serious consequences of the condition.
https://immattersacp.org/archives/2021/02/detecting-eating-disorders-in-midlife.htm
1 Feb 2021
MKSAP Quiz: Evaluation for daytime sleepiness
A 72-year-old man is evaluated for daytime sleepiness. His wife notes that he snores. He sleeps 8 hours each night. On most days of the week, he feels sleepy and will nap for 45 minutes. Following a physical exam and review of a previous procedure, what is the most appropriate test?
https://immattersacp.org/weekly/archives/2023/08/08/3.htm
8 Aug 2023
A living guideline for depression treatment
ACP recommends choosing between a second-generation antidepressant or cognitive behavioral therapy for adults in the acute phase of moderate to severe major depressive disorder.
https://immattersacp.org/archives/2023/06/a-living-guideline-for-depression-treatment.htm
1 Jun 2023
CA-125-guided therapy may improve outcomes for acute heart failure vs. standard of care
A multicenter randomized trial compared postdischarge therapy in patients who were hospitalized for acute heart failure and had high CA-125 levels.
https://immattersacp.org/weekly/archives/2016/08/16/4.htm
16 Aug 2016
Anticoagulation for heart failure and afib associated with reductions in mortality, but maybe not readmissions
Starting anticoagulation for older patients with heart failure and atrial fibrillation at hospital discharge was associated with improved mortality at 1 and 3 years but was not associated with improved rates of all-cause cardiovascular readmission or stroke, a study found.
https://immattersacp.org/weekly/archives/2014/09/16/6.htm
16 Sep 2014
AHA evaluates heart failure risks from prescription drugs, OTCs, alternative products
The scientific statement identifies prescription medications that may exacerbate underlying myocardial dysfunction, prescription drugs known to cause direct myocardial toxicity, and the sodium level of some over-the-counter medications, among other concerns.
https://immattersacp.org/weekly/archives/2016/07/19/5.htm
19 Jul 2016
More clarity on myocarditis with mRNA COVID-19 vaccines
The classic presentation for COVID-19 vaccine-associated myocarditis is chest pain one to seven days after vaccination, with a median time of three days after vaccination, particularly after the second dose.
https://immattersacp.org/archives/2023/02/more-clarity-on-myocarditis-with-mrna-covid-19-vaccines.htm
1 Feb 2023
Prescription NSAIDs associated with heart failure risk, study finds
A 19% increased risk for hospital admission for heart failure was found to be associated with any use of NSAIDs in the preceding 14 days versus past use of any NSAIDs. Diclofenac, ibuprofen, indomethacin, ketorolac, naproxen, nimesulide, piroxicam, etoricoxib, and rofecoxib were associated with increased risk for hospital admission.
https://immattersacp.org/weekly/archives/2016/10/04/1.htm
4 Oct 2016